Skip to main content
. 2015 Nov 9;10(11):e0142279. doi: 10.1371/journal.pone.0142279

Fig 3. Kaplan-Meier survival analysis of overall survival on 28 patients with death outcome.

Fig 3

(A) Survival comparison between High-MRS and Low-MRS groups. (B) Survival comparison among ER+/- patients. (C) Survival comparison among PR+/- patients. (D) Survival comparison among Her2+/- patients.